CLPBY (Coloplast AS) Short-Term Capital Lease Obligation: $40 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLPBY Coloplast AS CLPBY
77 GF Score
Price $6.72
GF Value $13.05
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Coloplast AS Short-Term Capital Lease Obligation?

Coloplast AS CLPBY -1.18% 77 Short-Term Capital Lease Obligation is $40 Mil as of Mar. 2026. GuruFocus rates CLPBY with a GF Score™ of 77/100 and a GF Value™ of $13.05 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Coloplast AS's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2026 was $40 Mil.

Coloplast AS's quarterly Short-Term Capital Lease Obligation declined from Sep. 2025 ($41 Mil) to Dec. 2025 ($41 Mil) and declined from Dec. 2025 ($41 Mil) to Mar. 2026 ($40 Mil).

Coloplast AS's annual Short-Term Capital Lease Obligation increased from Sep. 2023 ($33 Mil) to Sep. 2024 ($38 Mil) and increased from Sep. 2024 ($38 Mil) to Sep. 2025 ($41 Mil).

Coloplast AS Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Coloplast AS Short-Term Capital Lease Obligation Related Terms

Coloplast AS Short-Term Capital Lease Obligation Historical Data

* Premium members only.

The historical data trend for Coloplast AS's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS Short-Term Capital Lease Obligation Chart

Coloplast AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.00 27.80 32.92 37.66 41.20

Coloplast AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.98 39.27 41.20 40.76 39.91
CLPBY
77GF Score
Coloplast AS CLPBY
Short-Term Capital Lease Obligation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Short-Term Capital Lease Obligation of $40 Mil mean?
Coloplast AS (CLPBY) has a Short-Term Capital Lease Obligation of $40 Mil as of Mar. 2026.
Is Coloplast AS's Short-Term Capital Lease Obligation too high?
Coloplast AS's current Short-Term Capital Lease Obligation is $40 Mil. Overall, Coloplast AS has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Short-Term Capital Lease Obligation compare to ISRG and BDX?
Coloplast AS's Short-Term Capital Lease Obligation of $40 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Capital Lease Obligation for a Medical Devices & Instruments company?
A good Short-Term Capital Lease Obligation depends on the Medical Devices & Instruments industry context. However, Short-Term Capital Lease Obligation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Capital Lease Obligation mean?
A high Short-Term Capital Lease Obligation can signal that a stock is expensive relative to its fundamentals. Coloplast AS's current Short-Term Capital Lease Obligation is $40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $13.05, compared to a current price of $6.72 — trading 48.5% below its estimated fair value. The current Short-Term Capital Lease Obligation is $40 Mil. Coloplast AS's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Capital Lease Obligation calculated?
Short-Term Capital Lease Obligation is calculated from a company's financial statements. For Coloplast AS (CLPBY), the current Short-Term Capital Lease Obligation is $40 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coloplast AS (CLPBY) Overvalued in 2026?

Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued. The current stock price of $6.72 is trading 48.5% below its estimated GF Value™ of $13.05. GuruFocus considers Coloplast AS to be Significantly Undervalued.

Key valuation signals for CLPBY:

  • Short-Term Capital Lease Obligation: $40 Mil
  • GF Value™: $13.05 vs. price of $6.72 (48.5% below fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the CLPBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coloplast AS Business Description

Address Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
77GF Score

Get the complete analysis for CLPBY

Short-Term Capital Lease Obligation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.72
Price
$13.05
GF Value